Stockscreener 앱 받기
4.57
6.73%
-0.33
시간 외 거래:
4.63
0.06
+1.31%
Alvotech 주식(ALVO)의 최신 뉴스
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged ... - Bluefield Daily Telegraph
Transactions of Managers and Closely Associated Persons - The Manila Times
Viðskipti stjórnenda og tengdra aðila - GlobeNewswire Inc.
Alvotech Founder Róbert Wessman to Hand CEO Role to Lisa Graver in Planned Q1 2026 Succession - TipRanks
Startup Alvotech secures €100 mn term loan to fund 2026 execution - Beinsure
Alvotech names Lisa Graver as new CEO as founder steps back - Investing.com
Alvotech names Lisa Graver as new CEO as founder steps back By Investing.com - Investing.com Canada
Alvotech CEO Robert Wessman to step down, Lisa Graver to succeed - TipRanks
Alvotech Announces Leadership Transition: Róbert Wessman Remains Executive Chairman, Lisa Graver Appointed CEO - Quiver Quantitative
Alvotech announces planned CEO succession and leadership transition - GlobeNewswire
Alvotech Secures $100 Million Term Loan Facility Led By GoldenTree - Pulse 2.0
Alvotech (NASDAQ:ALVO) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
ALVO Investigation: Investors Encouraged to Contact Kirby McInerney LLP - FinancialContent
A Look At Alvotech (ALVO) Valuation After New US$100 Million Term Loan To Fund Biosimilar Pipeline - simplywall.st
Alvotech raises USD 100 million term loan to bolster biosimilar growth and 2026 launches - MSN
Icelandic biotech Alvotech secures to supercharge biosimilars pipeline and supply chain - Tech Funding News
Alvotech : Managers’ transactionsMTN ATP 19.12EN - marketscreener.com
Alvotech : Managers' transactionsALVOTECH - marketscreener.com
Alvotech (NasdaqGM:ALVO) Valuation Check After New $100 Million GoldenTree Term Loan for Biosimilar Growth - Yahoo Finance
The Truth About Alvotech: Why Everyone on Wall Street Suddenly Cares - AD HOC NEWS
Alvotech Stock Analysis and ForecastInstitutional Buying Trends & Free Superior Profit Margins - earlytimes.in
Alvotech secures USD 100M term loan - Medical Buyer
ROSEN, LEADING INVESTOR COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action InvestigationALVO - ACCESS Newswire
Alvotech Raises USD 100 Million Term Loan to Bolster Biosimilar Growth and 2026 Launches - TipRanks
Alvotech’s Volatile Ascent: Can A High?Beta Biosimilar Pure Play Keep Its Momentum? - AD HOC NEWS
Alvotech secures $100 million loan facility - Biostock
Icelandic BioTech Alvotech secures €100 million term loan facility to bolster liquidity and R&D investment - EU-Startups
What analysts say about Alvotech Z45 stockEarnings Forecast Updates & Double Digit Returns - earlytimes.in
Alvotech, Teva reach settlement with Regeneron over Eylea biosimilar AVT06 in US - MSN
ALVO Investor News: If You Have Suffered Losses in Alvotech - GlobeNewswire
Alvotech Secures USD 100 Million Senior Term Loan to Enhance Liquidity and Support R&D Initiatives - Quiver Quantitative
Alvotech Secures Term Loan Facility of USD 100 Million - The Manila Times
Alvotech (NASDAQ:ALVO) Trading 2.9% HigherShould You Buy? - MarketBeat
Alvotech Investor News: Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action InvestigationALVO - PR Newswire
Alvotech announced that it has received $100 million in funding - marketscreener.com
The Technical Signals Behind (ALVO) That Institutions Follow - Stock Traders Daily
Alvotech Files Notification with CSSF Regarding Changes in Own Shares - Quiver Quantitative
Changes in company's own shares - marketscreener.com
Alvotech : Changes in company's own shares - marketscreener.com
Alvotech : Acquisition or disposal of the issuer's own sharesALVOTECH - marketscreener.com
EV Market: Why Alvotech stock is favored by top institutionsMarket Sentiment Review & Growth Oriented Trading Recommendations - moha.gov.vn
Mereo BioPharma, Ultragenyx Pharmaceutical And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Why Bolt Projects Holdings Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket - Benzinga
Alvotech (NASDAQ:ALVO) Short Interest Down 41.1% in December - MarketBeat
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action InvestigationALVO - ACCESS Newswire
Is Alvotech stock near bottom after declineSwing Trading Watchlist & Build Wealth Brick by Brick With Us - bollywoodhelpline.com
Alvotech Investor News: Rosen Law Firm Encourages Alvotech Inves - GuruFocus
Alvotech (NASDAQ:ALVO) Trading Up 6.8%Time to Buy? - MarketBeat
Alvotech (ALVO): Firm reaffirms 2025 growth outlook - MSN
Alvotech Begins European Rollout of First-Ever Simponi Biosimilar Gobivaz - TipRanks
Why Alvotech (ALVO) Is Down 8.5% After Securing a 2026 US Entry Window for AVT06 - simplywall.st
Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma - Sahm
Alvotech announces European launch of biosimilar to Simponi - MSN
Alvotech/Advanz First to Launch Golimumab Biosimilar Worldwide - Pearce IP
Alvotech’s Financial Calendar for 2026 - The Manila Times
Alvotech : Financial Calendar for 2026 - marketscreener.com
0.29%
자본화:
|
볼륨(24시간):